DIODOQUIN

Welcome to the Brand page for “DIODOQUIN”, which is offered here for Tablets for use in treatment of entameba histolytica and other protozoan infections;.

Its status is currently believed to be active. Its class is unavailable. “DIODOQUIN” is believed to be currently owned by “G.D. SEARLE & CO.”

Competing brands may differ from DIODOQUIN by offering different formulations, dosages, or additional active ingredients for treating similar conditions. They may also have alternative methods of administration or different brand names.DIODOQUIN is a good brand because it offers tablets specifically designed for the treatment of entameba histolytica and other protozoan infections. Its active ingredient and formulation cater to addressing these particular health concerns effectively.

Owner:	G.D. SEARLE & CO. Owner Details
Description:	TABLETS FOR USE IN TREATMENT OF ENTAMEBA HISTOLYTICA AND OTHER PROTOZOAN INFECTIONS;
Categories:	TABLETS FOR USE IN TREATMENT